跳至主要内容
临床试验/ACTRN12619000793112
ACTRN12619000793112
招募中
未知

Smart Phone based single lead ECGs versus traditional ambulatory Holter monitoring for definite diagnosis of cardiac arrhythmias in patients with symptomatic palpitations: a randomised controlled trial

Western Sydney Local Health District (WSLHD)0 个研究点目标入组 80 人2019年5月29日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
Western Sydney Local Health District (WSLHD)
入组人数
80
状态
招募中
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2019年5月29日
结束日期
待定
最后更新
6年前
研究类型
Interventional
性别
All

研究者

发起方
Western Sydney Local Health District (WSLHD)

入排标准

入选标准

  • 1\.Patients aged greater than or equal to 18 years;
  • 2\.Symptomatic palpitations in whom initial 12 lead ECG has failed to detect arrhythmia.
  • 3\.At least two episodes of palpitations in the preceding 6 months;
  • 4\.Have a smartphone and/or a smartwatch capable of running the Alivecor application.

排除标准

  • Patients will be excluded if they are:
  • 1\.are unable or unwilling to provide informed consent;
  • 2\.Patients in whom palpitations are known to have a physiologic such as anaemia, thyroid dysfunction, heart failure, or women who are pregnant or breast feeding;
  • 3\.Concomitant illness, physical impairment or mental condition which in the opinion of the study team/ primary care physician could interfere with the conduct of the study including outcome assessments;
  • 4\.Inability or unwillingness to provide written informed consent;
  • 5\.Unable to complete study procedures;
  • 6\.Medical illness with anticipated life expectancy \< 3 months;
  • 7\.Responsible primary care or other responsible physician believes it is not appropriate to participate in the study.
  • 8\.poor baseline sECG recording;
  • 9\.Lack of understanding of how to record sECG after initial consultation.

结局指标

主要结局

未指定

相似试验